Clinical Trials Browser

Recruiting × Triple Negative Breast Neoplasms × Drug Therapy × Clear all

Triple Negative Breast Neoplasms

NCT06627712 2026-01-30

SBRT Combined With PD-1 Inhibitor and Chemotherapy in Early-stage TNBC

Phase 3 Recruiting

318 enrolled

Breast

Triple Negative Breast Neoplasms

NCT06635980 2025-12-12

Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast Cancer

Phase 2 Recruiting

120 enrolled

Breast

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT05076682 2025-12-03

Renaissance

Phase 2 Recruiting

80 enrolled

Breast

Triple Negative Breast Neoplasms

NCT07108309 2025-08-07

AREAL

Phase 2 Recruiting

124 enrolled

Breast

Triple Negative Breast Neoplasms

NCT07104266 2025-08-05

Triple Negative Breast Cancer and Celecoxib. Pilot Study

Phase 2 Recruiting

30 enrolled

Breast

Triple Negative Breast Neoplasms

NCT04638751 2024-04-05

ARGONAUT: Stool and Blood Sample Bank for Cancer Patients

Recruiting

5,000 enrolled

BreastGastrointestinalThoracic

Carcinoma, Non-Small-Cell Lung, Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms, Triple Negative Breast Neoplasms

NCT05999149 2024-02-21

BCTOP-T-N01

Phase 3 Recruiting

424 enrolled

Breast

Triple Negative Breast Neoplasms

NCT05916755 2023-06-23

PORTRAIT

Recruiting

100 enrolled

Breast

Triple Negative Breast Neoplasms

Clinical Trials

QL1706 Plus Chemotherapy as Neoadjuvant Therapy in Triple-Negative Breast Cancer

SBRT Combined With PD-1 Inhibitor and Chemotherapy in Early-stage TNBC

Hypofractionated Radiotherapy Before or After Breast Surgery for Treatment of Patients With Non-Metastatic Breast Cancer

Renaissance

AREAL

Triple Negative Breast Cancer and Celecoxib. Pilot Study

ARGONAUT: Stool and Blood Sample Bank for Cancer Patients

BCTOP-T-N01

PORTRAIT